TELFAST, anti allergy drug, capsules contain an active ingredient called "fexofenadine". It is one of a group of medicines called "antihistamines".
Antihistamines relieve the symptoms of hayfever (seasonal allergic rhinitis) such as
sneezing, itchy/watery red eyes and itchy/runny nose by blocking the action of histamine
which causes these unwanted effects.
The product is a non-sedation antihistamine which Means it has been shown not to make you
drowsy Or slow down your reactions.
Do not take this drug, and tell your doctor or pharmacist, if: you have had an allergic reaction to fexofenadine terfenadine (Teldanea) or any of the other ingredients in TELFAST (Allegra). These are listed at the end if this leaflet, the expiry date on the pack has passed. It may have no effect or an unexpected effect, if it is taken after this date, the packaging is torn or shows signs of tampering.
Before taking the drug: you should
inform your pharmacist/doctor if: you are, or might be pregnant, you are breast
feeding
you are taking other medications.
Your pharmacist/doctor will consider these points. When recommending TELEFAST, anti
allergy drug.
Use in children: there is currently insufficient information available to recommend the drug for use in children under 12 years of age.
Take TELFAST with a glass of water as directed
by your pharmacist/doctor. This product may be taken with or without food.
The usual dosage for adults and children over 12 years is one capsule twice daily, when
required.
Do not take more than the recommended dose, and remember, this medicine is for you. Never
give it to anyone else, even if their symptoms seem to be the same as yours.
Seasonal allergic rhinitis is an acute condition. You should seek the advice of your
doctor or pharmacist if you need more than 14 days continous treatment.
If the capsules do not relieve your symptoms, do Not take extra capsules. Tell your doctor
or pharmacist.
Tell your doctor or pharmacist as soon as
possible if you do not feel well while taking the medicine, even if you do not think the
problem is connected with the medicine or is not listed in this leaflet.
All medicines can cause side effects. Although most people will not experience any, some
of the side effects that may occur with This drug are: headache, tiredness, nausea,
indigestion.
These same effects were seen in patients taking dummy or placebo capsules during the
clinical studies.
TELFAST capsules have a white cap and a pink body. The product is available in blister packs of 20 capsules.
Each TELFAST capsule contains 60 mg of the
active ingredient fexofenadine hydrochloride which is equivalent to 55.9 mg of
fexofenadine.
There are also several inactive ingredients that are used in the manufacture of the
product. These are: lactose, pregelantinised starch, microcrystalline cellulose, gelatin
and croscarmellose sodium, iron oxide red (C177491), titanium dioxide, silicon dioxide and
sodium lauryl sulfate. TELFAST (Allegra) capsules, anti allergy drug, contain
no gluten or preservatives. Telfast decongestant contains
an antihistamine and a decongestant.
ALLEGRA-D or TELFAST-D (decongestant) CONTAINS 10 TABLETS, EACH TABLET CONTAINS fexofenadine HCl 60 mg/pseudoephedrine HCl 120 mg) extended-release tablets.
Allegra-D (fexofenadine HCl
60mg/pseudoephedrine HCl 120mg) extended-release tablets containing pseudoephedrine (the
decongestant in most over-the-counter allergy medicines), Allegra-D must not be taken if
you are also taking MAO inhibitors (medicines that treat depression) or if you retain
urine or have glaucoma, severe high blood pressure, or severe heart disease. Also, let
your doctor know before you take Allegra-D if you have high blood pressure, diabetes,
heart disease, glaucoma, thyroid disease, impaired kidney function, or symptoms of an
enlarged prostate such as difficulty urinating. The most commonly reported adverse
experiences with twice-daily Allegra-D extended release tablets compared to
pseudoephedrine alone in seasonal allergic rhinitis with nasal congestion in patients 12
and older were headache (13.0% vs. 17.4%), insomnia (12.6% vs. 13.3%), and nausea (7.4%
vs. 5.0%).
